CClinicalTrials.gg
CompletedNCT03654950PEPPUpdated Nov 7, 2022

Patient Empowerment With the Patient Perspective

An observational study in Colorectal Cancer, sponsored by Sahlgrenska University Hospital. Completed at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-11-07.

Sponsored by Sahlgrenska University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

The overall aim with this study is to gain a deeper understanding of patient perceptions regarding empowerment in relation to a health platform.

Read the detailed description

This is a two-stage study design. The first stage consists of focus groups interviews. Three focus groups with 6-8 patients (colorectal cancer patients diagnosed at least one year ago) in each group, will be invited. The focus group interviews will be moderated by one researcher, but accompanied with a second observing researcher. The participants will be identified using the regional Swedish ColoRectal Cancer Registry in Västra Götaland. The participants will be contacted by a short letter (appendix) indicating that we will call them with more information. The participants will by phone be asked to participate in the study and then invited to the focus groups.

The second phase of the project includes a questionnaire, which will be sent to 200 patients from the same population. The questionnaires will be delivered by using the Sunet Survey system, which is a system approved by University of Gothenburg. If the participants prefers a paper copy, or lack the possibility to reply online, a paper copy will be send via mail instead.

At this moment the investigators have developed a questionnaire, which may be refined due to the understating achieved from the focus group interviews.

02

Conditions studied

  • Colorectal Cancer
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's enrollment of 200 is below the median of 250 across 1,226 observational studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

Sahlgrenska University Hospital is the lead sponsor of 259 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients with colorectal cancer

Inclusion criteria

  • Patient with colorectal cancer

Exclusion criteria

Exclusion Criteria:

  • Inability to give informed consent or speaking and reading the Swedish language.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
200 participants (actual)
Patient registry
No

Interventions

  • OtherNo intervention

    Interviews and questionnaires

06

What researchers measure

Primary outcomes

  1. Patient reported experiences in themes

    interview

    Time frame: 1 day

Secondary outcomes

  1. Patient reported experiences divided into themes

    Interview

    Time frame: 12 months

07

Study locations

1 site
  • Dept. of Surgery, Sahlgrenska University Hospital/Ostra
    Gothenburg, SE 416 85, Sweden
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 7, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03654950
Lead sponsor
Sahlgrenska University Hospital
Collaborators
Högskolan Väst
Responsible party
Eva Angenete (Associate professor, consultant surgeon, Sahlgrenska University Hospital) — Principal investigator
First posted
Aug 31, 2018
Start date
Jun 1, 2018
Primary completion
Nov 1, 2021
Completion
Dec 1, 2021
Last update
Nov 7, 2022

Study contacts

Eva Angenete
principal investigator · Sahlgrenska University Hospital and University of Gothenburg

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion